![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 213/81 | (2006.01) |
A61K 31/44 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2097381 |
(13) | Kind of document | T |
(96) | European patent application number | 07818583.2 |
Date of filing the European patent application | 2007-09-29 | |
(97) | Date of publication of the European application | 2009-09-09 |
(45) | Date of publication and mention of the grant of the patent | 2013-06-19 |
(46) | Date of publication of the claims translation | 2013-10-25 |
(86) | Number | PCT/EP2007/008503 |
Date | 2007-09-29 |
(87) | Number | WO 2008/043446 |
Date | 2008-04-17 |
(30) | Number | Date | Country code |
06021296 | 2006-10-11 | EP |
(72) |
GRUNENBERG, Alfons, DE
STIEHL, Juergen, DE
TENBIEG, Katharina, DE
KEIL, Birgit, DE
|
(73) |
Bayer HealthCare LLC,
100 Bayer Boulevard, Whippany, NJ 07981,
US
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | 4-[4-({[4-Chlor-3-(trifluormetil)fenil)]karbamoil}amino)-3-fluorfenoksi]-N-metilpiridin-2-karboksamido monohidratas |
4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)]CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE MONOHYDRATE |
Payment date | Validity (years) | Amount | |
2025-08-28 | 19 | 347.00 EUR |
2026-09-29 |